China’s Venus Medtech acquired U.S. company InterValve to create a systematic TAVR treatment and strengthen its global expansion.
Venus Medtech announced in this month that it has purchased U.S. Company InterValve, the supplier of balloon aortic valvuloplasty products, and that the relevant delivery procedures have been completed recently.
China Med Device, LLC, specializing in providing turn-key solutions for medtech companies‘ entry into China, brings you up-to-date information on China’s medtech and medical device market. Contact our team at info@ChinaMedDevice.com or visit us at http://www.ChinaMedDevice.com. We can help you tap into the fast-growing China market and accelerate your product’s entry.